SUBSCRIBERS

Hyphens inks MOU with AStar's Accelerate

The five-year commercialisation deal covers development of products targeting eczema, acne, pigmentary disorders

Published Thu, Mar 21, 2019 · 09:50 PM

Singapore

SGX Catalist-listed Hyphens Pharma International Limited signed a Memorendum of Understanding (MOU) with A*Star's commercial arm A*ccelerate, previously known as Exploit Technologies, at the opening ceremony of its corporate headquarters and integrated facility in Singapore on Wednesday.

Lim See Wah, Hyphen Pharma's chairman and CEO, said: "Ou…

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes